Advisory Services Network, LLC Intra Cellular Therapies, Inc. Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$46.37 - $73.65 $20,495 - $32,553	442 New	442 $31,000
Q4 2022 Feb 13, 2023	BUY	$44.07 - $54.45 $25,031 - $30,927	568 New	568 $30,000
Q3 2021 Nov 05, 2021	SELL	$28.72 - $42.49 $22,258 - $32,929	-775 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$29.3 - $44.5 $22,707 - $34,487	775 New	775 $32,000
Q1 2021 May 24, 2021	SELL	$30.8 - $39.51 $23,870 - $30,620	-775 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$23.34 - $32.22 $22,173 - $30,609	-950 Reduced 55.07%	775 $25,000
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $30,377 - $54,958	1,725 New	1,725 $44,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.